EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biomedical Promise of Aspergillus Flavus-Biosynthesized Selenium Nanoparticles: A Green Synthesis Approach to Antiviral, Anticancer, Anti-Biofilm, and Antibacterial Applications

Eman Jassim Mohammed iD, Ahmed E M Abdelaziz iD, Alsayed E Mekky, Nashaat N Mahmoud, Mohamed Sharaf iD, Mahmoud M Al-Habibi iD, Nehal M Khairy iD, Abdulaziz A Al-Askar, Fady Sayed Youssef iD, Mahmoud Ali Gaber, Ebrahim Saied iD, Gehad AbdElgayed und 2 weitere

Pharmaceuticals · 09.07.2024 · 17 (7) · 915

DOI: 10.3390/ph17070915 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 09.07.2024. Verfasst von Eman Jassim Mohammed und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, College of Science, Mustansiriyah University, Baghdad 14022, Iraq. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Saud University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study utilized Aspergillus flavus to produce selenium nanoparticles (Se-NPs) in an environmentally friendly and ecologically sustainable manner, targeting several medicinal applications. These biosynthesized Se-NPs were meticulously characterized using X-ray diffraction (XRD), Fourier-transform infrared (FT-IR) spectroscopy, transmission electron microscope (TEM), and UV–visible spectroscopy (UV), revealing their spherical shape and size ranging between 28 and 78 nm. We conducted further testing of Se-NPs to evaluate their potential for biological applications, including antiviral, anticancer, antibacterial, antioxidant, and antibiofilm activities. The results indicate that biosynthesized Se-NPs could be effective against various pathogens, including Salmonella typhimurium (ATCC 14028), Bacillus pumilus (ATCC 14884), Staphylococcus aureus (ATCC 6538), Clostridium sporogenes (ATCC 19404), Escherichia coli (ATCC 8739), and Bacillus subtilis (ATCC 6633). Additionally, the biosynthesized Se-NPs exhibited anticancer activity against three cell lines: pancreatic carcinoma (PANC1), cervical cancer (Hela), and colorectal adenocarcinoma (Caco-2), with IC50 values of 177, 208, and 216 μg/mL, respectively. The nanoparticles demonstrated antiviral activity against HSV-1 and HAV, achieving inhibition rates of 66.4% and 15.1%, respectively, at the maximum non-toxic concentration, while also displaying antibiofilm and antioxidant properties. In conclusion, the biosynthesized Se-NPs by A. flavus present a promising avenue for various biomedical applications with safe usage.

Schlagwörter

Stichwörter der Autor:innen

Aspergillus flavusanticancer activityantiviral activitybiosynthesizedmedicinal applicationsselenium nanoparticles

Autor:innen und Institutionen

  • Department of Microbiology, College of Science, Mustansiriyah University, Baghdad 14022, Iraq.
  • Botany and Microbiology Department, Faculty of Science, Port-Said University, 23 December Street, Port-Said 42522, Egypt.
  • Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Nasr City, Cairo 11884, Egypt.
  • Biochemistry and Molecular Biology Department, College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China.
  • Department of Biochemistry, Faculty of Agriculture, AL-Azhar University, Nasr City, Cairo 11651, Egypt.
  • Microbiology and Immunology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Nasr City, Cairo 11651, Egypt.

ORCID-Profile: Eman Jassim Mohammed, Ahmed E M Abdelaziz, Mohamed Sharaf, Mahmoud M Al-Habibi, Nehal M Khairy, Fady Sayed Youssef, Ebrahim Saied, Shimaa A Metwally, Aly A Shoun

Förderung

  • King Saud University

Zitieren

APA

Mohammed, E. J., Abdelaziz, A. E. M., Mekky, A. E., Mahmoud, N. N., Sharaf, M., Al-Habibi, M. M., Khairy, N. M., Al-Askar, A. A., Youssef, F. S., Gaber, M. A., Saied, E., AbdElgayed, G., Metwally, S. A., & Shoun, A. A. (2024). Biomedical Promise of Aspergillus Flavus-Biosynthesized Selenium Nanoparticles: A Green Synthesis Approach to Antiviral, Anticancer, Anti-Biofilm, and Antibacterial Applications. Pharmaceuticals, 17(7), 915. https://doi.org/10.3390/ph17070915

Vancouver

Mohammed EJ, Abdelaziz AEM, Mekky AE, Mahmoud NN, Sharaf M, Al-Habibi MM, et al. Biomedical Promise of Aspergillus Flavus-Biosynthesized Selenium Nanoparticles: A Green Synthesis Approach to Antiviral, Anticancer, Anti-Biofilm, and Antibacterial Applications. Pharmaceuticals. 2024;17(7):915. doi:10.3390/ph17070915

BibTeX
@article{Mohammed2024,
  author = {Mohammed, Eman Jassim and Abdelaziz, Ahmed E M and Mekky, Alsayed E and Mahmoud, Nashaat N and Sharaf, Mohamed and Al-Habibi, Mahmoud M and Khairy, Nehal M and Al-Askar, Abdulaziz A and Youssef, Fady Sayed and Gaber, Mahmoud Ali and Saied, Ebrahim and AbdElgayed, Gehad and Metwally, Shimaa A and Shoun, Aly A},
  title = {Biomedical Promise of Aspergillus Flavus-Biosynthesized Selenium Nanoparticles: A Green Synthesis Approach to Antiviral, Anticancer, Anti-Biofilm, and Antibacterial Applications},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {7},
  pages = {915},
  doi = {10.3390/ph17070915}
}
Kostenlos starten →